Emergency and intensive care biomarkers
The GRC-14 BIOSFAST is dedicated to the study of emergency and intensive care biomarkers, and particularly the validation of their clinical usefulness and added-value, either for the diagnosis or the risk-stratification. The GRC-14 offers its expertise in several fields including infection and sepsis, head trauma, cardiac biomarkers, stress biomarkers, particularly through its 3 adult emergency departments, to design and conduct clinical trials in order to validate already marketed biomarkers but also upcoming R&D biomarkers.
Supervisory bodies
INSERM UMR-S 1166
Contact
Director
Pierre HAUSFATER
Phone : +33 1 42 17 72 40
Adress
83 boulevard de l’hôpital
75651 Paris Cedex 13
Mail of the director
pierre.hausfater@aphp.fr